UK markets closed

CytomX Therapeutics, Inc. (CTMX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5000+0.0800 (+5.63%)
At close: 04:00PM EDT
1.4600 -0.04 (-2.67%)
After hours: 06:25PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6557
Avg. Estimate-0.14-0.14-0.35-0.55
Low estimate-0.25-0.22-0.54-0.96
High estimate-0.01-0.02-0.15-0.28
Year ago EPS-0.020.04-0.01-0.35
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate19.99M20.99M102.87M76.56M
Low estimate10M12M79M36M
High estimate41.46M41.46M152.45M101M
Year ago salesN/A14.14M101.21M102.87M
Sales growth (year/est)N/A48.40%1.60%-25.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.2-0.19-0.03-0.08
Actual EPS-0.020.040.010.17
Difference0.180.230.040.25
Surprise %90.00%121.10%133.30%312.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.14-0.14-0.35-0.55
7 days ago-0.14-0.14-0.35-0.55
30 days ago-0.14-0.14-0.35-0.55
60 days ago-0.14-0.14-0.35-0.54
90 days ago-0.04-0.07-0.28-0.42
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCTMXIndustrySector(s)S&P 500
Current qtr.-600.00%N/AN/AN/A
Next qtr.-450.00%N/AN/AN/A
Current year-3,400.00%N/AN/AN/A
Next year-57.10%N/AN/AN/A
Next 5 years (per annum)-0.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A